MedTrace Logo

Study of Median Lobe Prostatic UroLift Procedure

NCT02625545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-02-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of using UroLift in subjects with a prostatic median lobe enlargement due to benign prostatic hyperplasia (BPH).

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

DEVICE

UroLift System procedure

Minimally invasive procedure for treatment of lower urinary tract symptoms (LUTS) due to BPH

Sponsors & Collaborators

  • NeoTract, Inc.

    lead INDUSTRY

Principal Investigators

  • Dan B. Rukstalis, M.D. · Wake Forest

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-17
Primary Completion
2017-05-30
Completion
2017-12-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02625545 on ClinicalTrials.gov